الاثنين، 19 أغسطس 2013

ScienceDaily: Health & Medicine News

ScienceDaily: Health & Medicine News

UC Davis researchers discover molecular target for the bacterial infection brucellosis

Posted: 15 Aug 2013 02:24 PM PDT

Scientists have uncovered a potential drug target for the development of an effective therapy against the debilitating, chronic form of the bacterial disease brucellosis, which primarily afflicts people in Mediterranean and Middle Eastern countries.

Type 1 diabetes study identifies subset of patients with strong response to therapy

Posted: 15 Aug 2013 02:22 PM PDT

Primary results from a new clinical trial show that a discrete subset of patients with type 1 diabetes treated with the monoclonal antibody teplizumab (MacroGenics, Inc.) demonstrated especially robust response with greater preservation of C-peptide, a biomarker of islet cell function, compared to controls, suggesting that these patients could be identified prior to treatment.

Chemists devise new way to prepare molecules for drug testing

Posted: 15 Aug 2013 01:15 PM PDT

James Bond had his reasons for ordering his martinis "shaken, not stirred." Similarly, drug manufacturers need to make sure the molecules in a new drug are arranged in an exact manner, lest there be dire consequences.

Smoking cessation experts weigh in on e-cigarettes

Posted: 15 Aug 2013 10:31 AM PDT

With the third and largest of the U.S. tobacco companies planning an e-cigarette product launch this fall, this next frontier for "Big Tobacco" provides renewed presence in a declining marketplace.
مرسلة بواسطة في

ليست هناك تعليقات:

إرسال تعليق

الاشتراك في: تعليقات الرسالة (Atom)